Dorsey Wright & Associates’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-2,655
Closed -$132K – 285
2021
Q4
$132K Buy
2,655
+360
+16% +$19K 0.03% 126
2021
Q3
$106K Buy
2,295
+180
+9% +$7.13K 0.02% 131
2021
Q2
$63K Hold
2,115
– – 0.01% 152
2021
Q1
$43K Buy
2,115
+1,215
+135% +$25.6K 0.51% 79
2020
Q4
$15K Buy
+900
New +$11.8K ﹤0.01% 215
2020
Q3
– Sell
-1,391
Closed -$9K – 305
2020
Q2
$9K Hold
1,391
– – ﹤0.01% 275
2020
Q1
$9K Buy
+1,391
New +$11.3K ﹤0.01% 155

Other funds holding ASPN

Dorsey Wright & Associates's ASPN Position: Q1 2022 in Review

Dorsey Wright & Associates sold out of Aspen Aerogels (ASPN) in Q1 2022, closing a stake of 2,655 shares — an estimated $132K sold.

Dorsey Wright & Associates first reported a position in ASPN in Q1 2020 and held it in 7 quarters. The position peaked at $132K in Q4 2021. 145 funds tracked by Wall St. Rank hold ASPN as of Q1 2022.

  • Dorsey Wright & Associates reported no remaining Aspen Aerogels position as of Q1 2022 after selling out during the quarter.
  • Dorsey Wright & Associates sold 2,655 Aspen Aerogels shares in Q1 2022, an estimated $132K.
  • Dorsey Wright & Associates first reported a position in Aspen Aerogels in Q1 2020 and held it in 7 quarters.
  • Dorsey Wright & Associates's Aspen Aerogels position peaked at $132K in Q4 2021.
  • 145 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2022.

Based on Dorsey Wright & Associates's 13F filing for Q1 2022, filed 27 Apr 2022.